Bumper Offer - Urjas oil Just @ Rs. 1
Triolmighty 20 Tablet is a commercial drug that is prescribed in the form of Tablet. Other than this, Triolmighty 20 Tablet has some other therapeutic uses, which have been discussed ahead.
Medical history of the patient along with age and gender determines the dosage of Triolmighty 20 Tablet. Individual symptoms and route of administration also determines the right dosage. Detailed information has been provided in the dosage section.
The side effects typically associated with Triolmighty 20 Tablet include Upper respiratory tract infection. Some other side effects of Triolmighty 20 Tablet have been listed ahead. Normally, these side effects of Triolmighty 20 Tablet are not long lasting and go away when the treatment is finished. Please speak with your doctor if these side effects worsen or persist for a longer duration.
Triolmighty 20 Tablet's effect during pregnancy is Safe and Safe while nursing. It is important to know if Triolmighty 20 Tablet has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Triolmighty 20 Tablet related warnings section.
Triolmighty 20 Tablet is not recommended if you suffer from certain medical conditions as it can have adverse effects. Bradycardia (Slow Heart Rate), Low Blood Pressure (Hypotension), Low Blood Pressure (Hypotension) are examples of such conditions. The section on Triolmighty 20 Tablet contraindications lists all such conditions.
Drug reaction of Triolmighty 20 Tablet with other medicines has been reported. Refer to the list below for further details.
Along with the above-mentioned precautions, remember that taking Triolmighty 20 Tablet is considered not safe while driving, and is not addictive.
Triolmighty 20 Tablet is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
Is the use of Triolmighty 20 Tablet safe for pregnant women?
Pregnant women can take Triolmighty without worrying about any side effects.
Is the use of Triolmighty 20 Tablet safe during breastfeeding?
Breastfeeding women can safely use Triolmighty.
What is the effect of Triolmighty 20 Tablet on the Kidneys?
Triolmighty has very mild side effects on the kidneys.
What is the effect of Triolmighty 20 Tablet on the Liver?
Triolmighty may have mild side effects on the liver. Most people will never see any effect on the liver.
What is the effect of Triolmighty 20 Tablet on the Heart?
Triolmighty has very mild side effects on the heart.
Triolmighty 20 Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Triolmighty 20 Tablet unless your doctor advises you to do so -
Is this Triolmighty 20 Tablet habit forming or addictive?
No, there is no any evidence that Triolmighty 20 Tablet is addictive.
Interaction between Food and Triolmighty 20 Tablet
When consumed with certain foods, Triolmighty 20 Tablet may take longer to have an effect. Contact your doctor about this.
Interaction between Alcohol and Triolmighty 20 Tablet
Taking alcohol with Triolmighty 20 Tablet can be dangerous.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Benicar (olmesartan medoxomil)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 507
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 169-173
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Norvasc® (amlodipine besylate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 540, 549, 550
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 147-148
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Hydrochlorothiazide
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 582-586
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 446-448
